ReviewBiomolecules2026
Circulating Bubbles in Decompression Sickness: Pathophysiology and Experimental Models.
Review in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Decompression sickness (DCS) is a severe condition caused by rapid reductions in ambient pressure during diving, altitude exposure, or aerospace operations, with circulating gas bubbles serving as a central initiating event. Stable nanobubbles on active hydrophobic spots along the vascular lumen can grow under decompression-induced supersaturation, detach, and enter the circulation. Their subsequent behavior is shaped by blood flow, vessel geometry, and coagulation and may lead to thrombosis and microvascular stasis. DCS pathogenesis involves three linked interfaces: the blood-bubble interface activates coagulation and complement; the bubble-endothelium interface causes mechanical injury, endothelial dysfunction, oxidative stress, and cell death; and the endothelium-immune interface, which promotes neutrophil recruitment and NETosis, driving sterile inflammation and microthrombosis. Experimental approaches reproduce different stages of this pathogenic sequence and can be broadly distinguished according to the origin of the bubbles. Whole-animal decompression models and whole-blood decompression systems incorporate pressure reduction or gas supersaturation and can therefore generate bubbles within the experimental system. Many endothelial-cell, vessel-based, and microfluidic platforms use pre-existing or externally generated gas bubbles that are introduced directly into the experimental system. These directly introduced-bubble models do not reproduce decompression-induced bubble genesis; however, they provide precise control over bubble size, flow, vascular geometry, and cellular interactions. They are therefore valuable for dissecting post-formation processes shared by decompression-generated and directly introduced intravascular bubbles, including bubble transport, vascular retention, endothelial injury, thrombosis, and inflammation. Recognizing this distinction in bubble origin is essential for defining the translational relevance and limitations of individual experimental models.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.